Skip to main content

Enveric Biosciences Rallies 300% As It Receives US Patents For Psychedelic Compounds

Enveric Biosciences (ENVB) has recently received two patents for its novel psychedelic compounds, which are modeled from psilocybin mushrooms.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.